StonvexLoading…
StonvexStonvexStonvexCore line items from SSNC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.65B | $6.27B | $4.62B | $3.05B |
Operating Income | $398.20M | $1.44B | $1.07B | $702.40M |
Net Income | $226.10M | $796.90M | $603.80M | $393.80M |
EPS (Diluted) | $0.91 | $3.15 | $2.39 | $1.55 |
Total Assets | $20.33B | $20.71B | $19.49B | $18.98B |
Total Liabilities | $13.43B | $13.77B | $12.50B | $11.97B |
Cash & Equivalents | $420.90M | $462.10M | $388.30M | $480.30M |
Free Cash Flow OCF − CapEx | $293.70M | $1.66B | $1.03B | $609.50M |
Shares Outstanding | 240.80M | 241.40M | 243.50M | 244.00M |